Category Archives: News

Clients in the News – Georgia State Researcher Wins Grant to Develop Ebola Virus Drug

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, [...]

Clients in the News – Stanford University: Antibody Fights 5 Types of Pediatric Brain Tumors

An immunotherapy successfully and safely treated five different types of aggressive pediatric brain tumors in [...]

Clients in the News – UMD Develops New Method that Enables Creation of Better Therapeutic Antibodies

Antibodies are the foot soldiers of our immune system. These specialized, Y-shaped proteins attach to [...]

Clients in the News – Frederick company pitches new device for deadly disease detection

  Sputum — a nasty mix of saliva and mucus — doesn’t come up in [...]

Clients in the News – UCLA: Nearly $9M in NHLBI Funding to Help Take Science Solutions to Heart

Thus far in 2017, the University of California Los Angeles has received over $6.8 million [...]

Clients in the News – NIH Grants Akonni $300K to Develop DNA Extraction Device for Molecular TB Testing

Molecular diagnostics firm Akonni Biosystems won a $300,000 contract from NIH’s National Institute of Allergy [...]

Clients in the News – UC San Diego Receives Two, $2M Research Grants from CIRM

The California Institute for Regenerative Medicine (CIRM) awarded two scientists at UC San Diego $2 [...]

Clients in the News – Maryland Cancer Discovery Incubator Finalists Announced

Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced the finalists for their [...]

Clients in the News – Duke University Engineers Use Tumor-Seeking Salmonella Treats Brain Tumors

Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the [...]

Clients in the News – Personal Genome Diagnostics’ ImmunoSELECT™ Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study

–ImmunoSELECT’s Comprehensive Multi-Dimensional Genomic Analyses Elucidated How the Cancer Neoantigen Landscape Evolved During Treatment with [...]

Clients in the News – University of Massachusetts: $4M Grant for Plant Stem Cell Research

Dr. Madelaine Bartlett, a biologist at the University of Massachusetts in Amherst, recently received a [...]

Clients in the News – Immunomic Therapeutics Announces Board Addition

Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces that C. Eric Winzer, M.B.A., [...]

Clients in the News – UW-Madison Food Scientist Aiding Fuel Ethanol with New Engineered Bacteria

For James Steele, moving from the small fermenters where microbes make cheese, wine, and beer [...]

Clients in the News – $10.3M in Alzheimer’s Research Funding Awarded to University of Arizona

The National Institute of Aging has awarded a five year, $10.3 million grant to the [...]

Clients in the News – University of South Florida to Participate in $150M Research Program

University of South Florida Nursing’s professor, Maureen Groer, PhD recently received funding to extend her [...]

Clients in the News – UPenn: $24 Million Award to Create New Mechanobiology Research Center

In late September the National Science Foundation awarded the University of Pennsylvania a five-year grant [...]

Clients in the News – $78.5M For New Research Facilities at University of Michigan

A $78 million project to renovate two empty buildings at the former pharmaceutical research complex [...]

Clients in the News – Immunomic Therapeutics Gives Back to Maryland Biotech Community

Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced they are now accepting [...]

Client in the News – Spaulding Clinical Research Named “Best Phase I Drug Development CRO”

Spaulding Clinical Research, LLC recognized as the 2016 International Life Sciences Award by Global Health [...]

Clients in the News – UPitt Finds Preliminary Zika Vaccines Prevent Neurological Disorders

Two vaccines against Zika virus developed at the University of Pittsburgh School of Medicine have [...]